Back to search

Article

Affordable mRNA Novel Proteins, Recombinant Protein Conversions and “Biosimilars”—Advice to Developers and Regulatory Agencies

2024-12-09

Abstract excerpt

The mRNA technology can replace the expensive recombinant technology for every type of protein, making biological drugs more affordable. It can also expedite the entry of new biological drugs, and the copies of approved mRNA products can be treated as generic or biosimilar products due to their chemical nature. Hundreds of new protein drugs have been blocked due to the high cost of recombinant development. The low...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6c4fa3f-8dc8-5b57-afe9-ade501622c1d
DOI
10.20944/preprints202412.0680.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Affordable mRNA Novel Proteins, Recombinant Protein Conversions and “Biosimilars”—Advice to Developers and Regulatory AgenciesDOI 10.20944/preprints202412.0680.v1
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospectsSemantic proximity
The global patent landscape of mRNA for diagnosis and therapySemantic proximity
mRNA-based modalities for infectious disease managementSemantic proximity
Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity
mRNA: vaccine or gene therapy? The safety regulatory issuesSemantic proximity
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!Semantic proximity
Advancements in mRNA Encoded Antibodies for Passive ImmunotherapySemantic proximity
mRNA cancer vaccines: Advances, trends and challengesSemantic proximity
mRNA vaccine development and applications: A special focus on tumors (Review)Semantic proximity
Improving access to gene therapy for rare diseasesSemantic proximity
mRNA Vaccine Technology Beyond COVID-19Semantic proximity
Optimizing regulatory frameworks for gene therapies in rare diseases: Challenges and solutionsSemantic proximity
Select a neighboring publication to make it the new centre.